The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SKYSCRAPER-08: A phase III, randomized, double-blind, placebo-controlled study of first-line (1L) tiragolumab (tira) + atezolizumab (atezo) and chemotherapy (CT) in patients (pts) with esophageal squamous cell carcinoma (ESCC).
 
Chih-Hung Hsu
Honoraria - Bristol-Myers Squibb; Eisai; Merck Sharp & Dohme; Ono Pharmaceutical; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Merck Serono; MSD; Ono Pharmaceutical; Roche/Genentech
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Eucure Biopharma (Inst); Johnson & Johnson (Inst); Merck Serono (Inst); MSD (Inst); NGM Biopharmaceuticals (Inst); Nucana (Inst); Ono Pharmaceutical (Inst); Roche/Genentech (Inst); Surface Oncology (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Zhihao Lu
No Relationships to Disclose
 
Shegan Gao
No Relationships to Disclose
 
Jun-Ye Wang
No Relationships to Disclose
 
Jong-Mu Sun
No Relationships to Disclose
 
Tianshu Liu
No Relationships to Disclose
 
Qingxia Fan
No Relationships to Disclose
 
Jun Cai
Employment - Roche
 
Feijiao Ge
Employment - Roche
 
Sijing Li
Employment - F. Hoffmann LaRoche
 
Li Zhang
Employment - Roche
Stock and Other Ownership Interests - Roche
Honoraria - Roche
Travel, Accommodations, Expenses - Roche
 
Edward Cha
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; SERVIER; Transcenta Holding Limited
Research Funding - BeiGene (Inst)